IDO1 is a target for cancer immunotherapy and encodes a heme enzyme that acts on multiple tryptophan substrates and plays a crucial role in pathophysiological processes such as immunoregulation, antitumor defense, and antioxidant activity29,30. The gene discussed is IDO1; the disease is cancer.